From introduction to integration—and everything in between
Healing Rituals brings research literacy, preparation, reflective support and integration resources into one grounded Aspen setting. Some people understand healing as spiritual or divine; others arrive through clinical curiosity, personal growth or a desire to make sense of an experience. Each perspective is welcomed without presenting spiritual meaning as scientific fact.
Effective support is not a promise of cure. It begins with honest information, clear scope, thoughtful screening and referral, respect for legal and clinical boundaries, and enough continuity to carry insight into daily life. Healing Rituals does not provide or administer controlled substances, and educational or integration support does not replace licensed medical or mental-health treatment.
Research and resources for every stage
This independent Healing Rituals collection connects carefully bounded research with practical questions for people exploring psychedelic healing in Aspen, the Roaring Fork Valley or from farther away. Begin where you are:
- Introduction, preparation and integration questions—how to clarify the kind of support you are seeking and evaluate provider scope.
- Set, setting and preparation research—what context may influence and what it cannot guarantee.
- A grounded integration guide—meaning-making, routines, relationships and clinical support after an experience.
- Ethics, confidentiality and referral—questions for choosing responsible integration support.
- End-of-life clinical research—what landmark psilocybin trials actually studied.
- Emerging Parkinson’s research—early findings and the important limits of a small study.
How this Aspen resource is different
This is Healing Rituals’ own educational and integration resource center. It is not a licensed natural-medicine healing center and does not provide or administer controlled substances. Its purpose is to translate original research, help readers ask better questions, and offer grounded nonclinical preparation and integration support. Clinical treatment and regulated facilitation require appropriately licensed providers; credentials can be checked through Colorado’s Office of Natural Medicine Licensure.
Depression research
A 2023 randomized trial involving 104 adults with major depressive disorder compared psilocybin with niacin, both accompanied by psychological support. The psilocybin group showed greater reductions in depressive symptoms over the six-week follow-up. Participants were screened, and the study used a defined clinical protocol. Read the JAMA trial.
This is evidence about that intervention in that population. It should not be presented as proof that every plant-assisted wellness experience offers the same benefits.
Research on alcohol use
NCCIH’s evidence overview describes a 2022 trial in which psilocybin sessions combined with psychotherapy reduced heavy drinking more than an active placebo combined with psychotherapy. The same overview discusses mixed findings in other comparisons and the importance of safety. Read the NIH summary.
Alcohol use disorder was the condition being studied. Extending that result to all addictions, or to unsupported use, would go beyond the evidence. If substance use is part of your concern, specialist assessment and an appropriate care plan matter.
The surrounding support is part of the evidence
Screening, preparation, monitoring and psychological support are not decorative extras in these trials. They are part of what researchers evaluated. The lasting effects of an experience cannot be judged only by how intense, moving or visually vivid it felt.
Research also needs to examine adverse effects, which people benefit and how outcomes change over longer follow-up. Psilocybin can cause distress and other adverse effects; it is not appropriate for everyone. A careful provider should be able to discuss both the possibilities and the risks.
Why expectancy and blinding complicate promising results
A 2026 systematic review examined blinding integrity across 112 randomized trials of psychedelics for psychiatric disorders. Only 33 trials assessed blinding integrity, and the review found pervasive functional unblinding among participants and raters; no control strategy consistently preserved ideal blinding. Read the PubMed abstract. This does not make positive trials meaningless, but it limits how confidently measured effects can be separated from expectancy and other parts of the treatment context.
The practical lesson is to examine the complete intervention: screening, licensed clinical oversight, preparation, therapeutic support and follow-up—not only the substance. Healing Rituals does not provide or administer controlled substances. Reflective preparation or integration support is not a substitute for legal medical care, and this article provides no dosing guidance.
Sources & further reading
These sources distinguish study findings from the practical reflections in this article.
- Raison et al. (2023): psilocybin for major depressive disorderRandomized clinical trial
- NCCIH: psilocybin, mental health and addiction researchNIH evidence overview
- Colorado DORA: Office of Natural Medicine LicensureOfficial state resource
- Orsini DK, Wong S, Di Luch S, et al. Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review. JAMA Psychiatry. 2026;83(7):755–769. doi:10.1001/jamapsychiatry.2026.0255.Systematic review of 112 randomized trials; only the abstract was accessible during this research check, and it concerns trial validity rather than treatment efficacy.
About this reading
A selected overview of the linked evidence, with practical interpretation for readers exploring this topic. It is not a systematic review or a clinical assessment.
Learn about Lauren and the practice